New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
18:32 EDTCLC, RHT, JBL, MEAS, QGEN, ALCS, OAKS, SDLP, EDROn The Fly: After Hours Movers
UP AFTER EARNINGS: CLARCOR (CLC), up 6.92% after reporting second quarter results... Red Hat (RHT), up 4.26%... Jabil Circuit (JBL), up 1.49% after reporting quarterly results and fiscal 2015 guidance. ALSO HIGHER: Measurement Specialties (MEAS), up 10.32% after TE Connectivity (TEL) announced it was acquiring the company for $1.7B... Qiagen (QGEN), up 2.85% after FDA approves artus CMV RGQ MDx kit. LOWER: Alco Stores (ALCS), down 2.88% after reporting that CFO Wayne Peterson has left the company... Five Oaks (OAKS), down 3.45% after filing to sell 3.5M shares of common stock... Seadrill Partners (SDLP), down 3.51%... Education Realty Trust (EDR), down 2.98%.
Check below for free stories on CLC;RHT;JBL;MEAS;QGEN;ALCS;OAKS;SDLP;EDR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 31, 2014
11:51 EDTRHTRed Hat management to meet with JMP Securities
Subscribe for More Information
July 29, 2014
16:14 EDTQGENQIAGEN sees Q3 adjusted EPS 26c-27c, consensus 27c
Sees Q3 adjusted net sales up 4%-5% CER.
16:13 EDTQGENQIAGEN reaffirms 2014 EPS outlook $1.07-1.09, consensus $1.09
Subscribe for More Information
16:12 EDTQGENQIAGEN announces new $100M share repurchase program
QIAGEN announced today the launch of its third $100M share repurchase program after completing its second $100M program in June. In the second repurchase program, approximately 4.5M shares were repurchased on the Frankfurt Stock Exchange.
16:12 EDTQGENQIAGEN reports Q2 adjusted EPS 26c, consensus 25c
Reports Q2 revenue $331.2M, consensus $330.8M.
July 28, 2014
06:15 EDTEDREducation Realty lowers 2014 core FFO view to 61c-64c from 62c-68c
Subscribe for More Information
06:12 EDTEDREducation Realty reports Q2 core FFO 15c, consensus 15c
Reports Q2 revenue $50.04M, consensus $47.03M. Reports same-community net operating income up 2.6%.
05:36 EDTQGENQIAGEN, AstraZeneca announce collaboration
QIAGEN (QGEN) announced a collaboration agreement with AstraZeneca (AZN) for the co-development and commercialization of a liquid biopsy-based companion diagnostic to be paired with IRESSA, AstraZeneca's targeted therapy for non-small cell lung cancer, or NSCLC. The project builds on a master framework agreement signed by both companies in 2013 and aims to develop and market a novel QIAGEN companion diagnostic that analyzes plasma samples to assess EGFR mutation status in NSCLC patients. The assay will be designed to guide the treatment of NSCLC patients with Astra Zeneca's oral monotherapy anti-cancer treatment when tumor tissue is not available. QIAGEN already offers the therascreen EGFR RGQ PCR Kit as a tissue-based companion diagnostic for lung cancer patients, which was approved in the U.S. by the FDA in July 2013 and in China in May 2014. The companies will collaborate to create a new companion diagnostic for IRESSA based on liquid biopsy samples from NSCLC patients, rather than requiring invasive surgical collection of tissue samples. Data from several studies, including the IFUM Study presented at the "World Lung 2013" conference, provided evidence of the ability to assess the EGFR status of advanced lung cancer patients using blood / plasma samples. This breakthrough provides hope for patients for whom surgical biopsy is not an option by enabling them to have their EGFR mutation status assessed using a less invasive method.
July 25, 2014
09:03 EDTJBLJabil Circuit announces $100M share repurchase program
Subscribe for More Information
July 24, 2014
16:17 EDTQGENQIAGEN acquires exclusive global license to the biomarker SF3B1
Subscribe for More Information
10:02 EDTJBLJabil Circuit downgraded to Buy from Conviction Buy at Goldman (pre-open)
Subscribe for More Information
July 22, 2014
09:34 EDTJBLJabil Circuit upgraded to Outperform from Sector Perform at Scotia Capital
Subscribe for More Information
09:13 EDTALCSCAS says Glass Lewis affirms need for change of ALCO Stores board
Concerned ALCO Stockholders announced that Glass Lewis & Co., LLC has joined Institutional Shareholders Services, Inc. in affirming the need for a change of the incumbent Board of Directors of ALCO Stores. GLís report released Monday, July 21, recommends that investors DO NOT VOTE for any of the incumbent Directors of the Company this year, including Messrs. Royce Winsten, Richard E. Wilson, Dennis E. Logue, Lolan C. Mackey, Terrence M. Babilla, Paul T. Davies, and Leslie A. Ball. Both Glass Lewis & Co. and Institutional Shareholders Services, Inc. recommend ALCO investors use the GOLD proxy card for voting.
08:47 EDTALCSALCO Stores responds to CAS group proxy solicitation materials
Subscribe for More Information
July 21, 2014
08:44 EDTALCSCAS says ISS affirms need for 'meaningful change' at ALCO Stores
Subscribe for More Information
07:15 EDTRHTO'Reilly to hold a conference
Subscribe for More Information
July 17, 2014
13:36 EDTSDLPSeadrill Partners increases cash distribution by 7% to 54.25c
Seadrill Partners announced that its board of directors has declared a quarterly cash distribution with respect to the quarter ended June 30 of 54.25c per unit, which represents an increase of approximately 7% from the 1Q14. This increase, as already announced, relates to the acquisition of the ultra-deepwater drillship, the West Auriga, and the company's management recommendation to the board to increase the quarterly distribution rate as a result in respect of the quarter ending June 30. This increase is not influenced by the accretion resulting from the acquisition of additional Seadrill Operating units announced. Distribution increases as a result of this acquisition will follow in subsequent quarters. This cash distribution will be paid on August 12 to all unitholders of record as of the close of business on July 31.
13:31 EDTSDLPSeadrill Partners acquires additional 28% interest in Seadrill Operating
Subscribe for More Information
10:00 EDTCLCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:23 EDTCLCClarcor upgraded to Outperform from Neutral at RW Baird
Baird upgraded Clacor (CLC) to Outperform citing improved core fundamentals, valuation and recent acquisition opportunities. Price target is $67.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use